Table 2.

Respondent Ratings of Blood Glucose Monitoring System, Insulin Delivery System, and Quality of Life by Treatment Group^a

Category measure	SMBG + CSII (Unadjusted)	RT-CGM/CSII (Unadjusted)	SMBG + CSII (Adjusted)	RT-CGM/CSII (Adjusted)
BG monitoring system
Convenience	62.4 ± 24.2	57.8 ± 22.8	61.8	58.2
Interference	17.5 ± 24.8b	30.6 ± 23.5	18.3b	30.0
BG burden	21.5 ± 33.9	22.3 ± 34.5	21.8	22.1
BG control	49.0 ± 24.4	69.1 ± 20.8b,c	48.2	69.8b,c
Cost satisfaction	50.6 ± 36.3	46.2 ± 40.8	50.2	46.5
Overall satisfaction	52.9 ± 26.2	62.5 ± 22.8b	52.2	64.4b
Switch BG monitoring system	58.3 ± 27.6	33.2 ± 24.4b,c	58.9	32.3b,c
Recommend BG monitoring system	69.2 ± 23.2	80.6 ± 21.6b,c	68.7	81.1b,c

Insulin delivery system
Convenience	70.7 ± 20.4	78.6 ± 16.9b	70.8	78.5b
Interference	25.1 ± 23.2	22.5 ± 20.4	25.5	22.9
BG burden	24.5 ± 33.6	18.2 ± 31.0	24.6	18.3
BG control	63.1 ± 22.2	68.7 ± 19.7d	62.8	69.0d
Cost satisfaction	44.4 ± 35.6	46.6 ± 35.1	44.6	46.5
Overall satisfaction	66.7 ± 22.5	73.4 ± 21.8d	66.9	73.2d
Switch insulin delivery system	38.4 ± 27.3	24.7 ± 21.9d	38.0	24.9b
Recommend insulin delivery system	82.9 ± 20.8	87.5 ± 17.8e	82.6	87.9e

Quality of life
Worries	48.4 ± 19.4	45.4 ± 18.4	48.7	45.1
Social burden	30.9 ± 18.7	32.4 ± 18.2	31.1	32.4
Positive well-being	55.6 ± 17.7	56.2 ± 17.0	55.4	56.4
Negative well-being	47.5 ± 21.1	42.2 ± 20.2e	47.1	42.7

^aCell entries are mean (± standard deviation); adjusted means obtained by analysis of covariance with covariates from Table 1 set to mean values.

^bp < .001 (more positive perception).

^cEffect size more than 0.5 pooled SDUs.

^dp < .01 (more positive perception).

^ep < .05 (more positive perception).